Are you recommending tocilizumab for any COVID-19 patients?
2
1 Answers
Mednet Member
Rheumatology · Northwestern Medical Group
The utility of IL-6 receptor inhibitors in COVID-19 is controversial, and I do not recommend its routine use in COVID-19 patients at this time. Although early observational studies of IL-6 receptor inhibitors in severe COVID-19 suggested potential benefits, an early RCT of tocilizumab vs. placebo (B...